Last week was a busy one in the world of biopharma: - Starboard Value took a $1 billion stake in Pfizer this week; - We announced our 20 Women in Biopharma; - Nobel Prizes highlighted the era of AI in biotech; - Judo Bio launched with $100M to target kidneys Want to get the top headlines of the week each Saturday? Sign up to Endpoints Weekly. https://lnkd.in/eZ73fdzr
Endpoints News
Online Audio and Video Media
Lawrence, KS 18,395 followers
The biopharma world is here
About us
Endpoints is the biopharma world's leading source for breaking news, smart analysis and exclusive access. We cover the intersection of science, money and power in the world's most innovative industry, and are a part of the Financial Times' FT Specialist group.
- Website
-
http://endpts.com
External link for Endpoints News
- Industry
- Online Audio and Video Media
- Company size
- 51-200 employees
- Headquarters
- Lawrence, KS
- Type
- Privately Held
- Founded
- 2014
- Specialties
- Biotechnology, News, Drug Development, and Pharmaceuticals
Locations
-
Primary
W 24th Pl
Lawrence, KS 66049, US
Employees at Endpoints News
Updates
-
After a week in which it began a showdown with an activist investor, was betrayed by and then reunited with two former top executives, and ended work on an RSV drug —Pfizer finally has some good, straightforward news. TGIF 😮💨 https://lnkd.in/ezasX9aX
Pfizer gets an FDA win in hemophilia after a rough week
endpts.com
-
Join us on October 20th at HLTH for our partner program, What’s Working — and What’s Not — in Direct-to-Consumer Care. Register with code EndpointsNe150 to save $250 on your ticket. More info on our partner program below. https://lnkd.in/ehHqAQwb #HLTH #HealthcareInnovation #BeBold
-
In a public letter Thursday to Pfizer’s board of directors, investor Starboard Value alleged that former CEO Ian Read and CFO Frank D’Amelio were threatened with a clawback of compensation and unvested stock, as well as potential litigation. https://lnkd.in/ev-75GEC
Starboard launches first salvo in Pfizer fight, alleging ex-CEO, CFO were pressured to flip
endpts.com
-
Endpoints News reposted this
Inside Thursday's Endpoints News newsletter: - Suki raises a Series D round as more $$ pours into AI scribes, Shelby Livingston reports - Ngai Yeung got the exclusive on Medicaid-focused Reema Health's Series A raise - more on the back and forth over compounded GLP-1s One big number re: weight loss drugs and more! Check it out: https://lnkd.in/deiZbd6r
Endpoints News — More money enters the AI scribe race; PBMs push back on FTC commissioners
reports.endpts.com
-
Endpoints News reposted this
The Pfizer vs Starboard activist fight just got wilder. It appears that the company was tipped to the activist investor's campaign after an erroneous email by one of the former execs aligned with Starboard. From me and Max Bayer at Endpoints News. https://lnkd.in/ebnfp4zZ
Exclusive: How an accidental email tipped Pfizer off to an activist investor’s plan
endpts.com
-
👀 👀 👀
🤯 This is one of the craziest corporate/executive reversals I've ever seen. Four days ago, Pfizer's ex-CEO and ex-CFO came out and backed activist investor Starboard Value. Late last night, they flipped and said they completely support management. I've been doing this for 20 years, and this is the messiest, craziest thing I've ever seen in a big company activist fight. https://lnkd.in/eCNTqmyC
Former Pfizer CEO and CFO flip on activist and say they now support company
endpts.com
-
Artificial intelligence has its Nobel Prize moment. On Tuesday, the Nobel Prize in Physics went to a pair of longtime AI pioneers in Geoffrey Hinton and John Hopfield. Then, on Wednesday, the committee awarded the Nobel Prize in Chemistry to David Baker, Demis Hassabis and John Jumper — three scientists leading the way in using AI to predict and design proteins. Baker, Hassabis and Jumper’s research is behind the creation of some of biotech’s most ambitious startups. That includes Isomorphic Labs, where Hassabis is CEO; and Xaira Therapeutics, which debuted earlier this year with over $1 billion in funding with Baker as a co-founder.
‘Just the beginning’: Nobel Prizes show the AI era has arrived in biotech
endpts.com
-
Endpoints News reposted this
Gene therapy pioneer Jim Wilson thinks he has a solution to the field’s struggle to commercialize breakthrough cures: Go global. I spoke with him about his new company securing up to $100 million in funding to manufacture and test six gene therapies in Brazil. The company's plan, funded by Brazil’s Ministry of Health, looks to produce the potential medicines at a fraction of the millions of dollars that they often cost. Drugmakers big and small have found that the price tag for gene therapies made them a tough sell, or impractical to develop.
Jim Wilson secures $100M for global approach aimed at reviving gene therapy field
endpts.com
-
Endpoints News reposted this
What was inevitable is now official: Lilly’s tirzepatide is no longer in shortage. Inside today's Endpoints News Health Tech newsletter, Shelby Livingston and I dive deeper into what that means for the compounding pharmacies that have been supplying versions of the medication to patients at lower prices to the branded version. The next month or so will certainly be an interesting time for the GLP-1 market. Be sure to subscribe for more updates! https://lnkd.in/gtb6vXgE
Endpoints News — What’s next as tirzepatide comes off shortage; Oaktree has a new SPAC
reports.endpts.com